Skip to main content
. 2018 Aug 6;9(17):3109–3116. doi: 10.7150/jca.25235

Table 1.

The correction between the expression of miR-302b, EphA2 and the clinicopathologic characteristics of patients in the training cohort.

Variable n EphA2 miR302b
High Low P High Low P
Age (years)
<60 123 89 34 0.684 54 69 0.128
≧60 103 77 26 35 68
Gender
Male 113 86 27 0.366 45 68 0.892
Female 113 80 33 44 69
Primary tumor location
Fundus and cardia 110 85 25 0.205 37 73 0.085
Distal third 116 81 35 52 64
Lauren's
Diffuse 131 94 37 0.498 47 84 0.206
Intestinal 95 72 23 42 53
Depth of invasion
T1 22 12 10 0.036 15 7 0.003
T2 55 37 18 27 28
T3 118 90 28 39 79
T4 31 27 4 8 23
Lymph node metastasis
Positive 136 110 26 0.002 43 93 0.003
Negative 90 56 34 46 44
TNM stage
I 23 10 13 <0.001 16 7 <0.001
II 52 33 19 31 21
III 67 52 15 19 48
IV 84 71 13 23 61
Lymphatic invasion
Yes 97 77 20 0.002 32 65 0.001
No 81 47 34 46 35
Venous invasion
Yes 56 43 13 0.161 22 34 0.409
No 122 81 41 56 66